A naukri.com initiative
Bioengineer
1w
197
Image Credit: Bioengineer
Innovative Diagnostic Tool Employs Bioluminescence to Identify Viruses
- A revolutionary diagnostic tool called LUCAS utilizes amplified bioluminescence to detect viruses rapidly and accurately within complex biological samples, addressing long-standing challenges in viral diagnostics.
- Traditional bioluminescence assays using luciferase have been limited by the weak and transient nature of emitted light signals, hindering their application in sensitive viral detection.
- The LUCAS technology integrates beta-galactosidase into the luciferase reaction system to create a biochemical feedback loop, resulting in a 500 times stronger and eight times longer-lasting bioluminescent signal.
- In testing with over 300 viral-infected samples, including SARS-CoV-2 and HIV, LUCAS showed remarkable diagnostic performance, with results available in under 23 minutes and accuracy exceeding 94%.
- Designed for portability and user accessibility, LUCAS can be deployed in various healthcare settings, offering rapid, reliable diagnostics at the point of care to enhance clinical decision-making.
- The LUCAS platform's modular approach holds potential for multiplexed pathogen detection and expansion beyond viruses to include biomarkers for various diseases, enhancing its clinical utility.
- This innovative technology exemplifies the forefront of personalized medicine diagnostics, emphasizing the importance of early detection in managing infectious diseases and improving patient outcomes.
- Backed by a multidisciplinary team, LUCAS's capabilities have been validated in a peer-reviewed publication, showcasing its potential commercial impact following a patent filing.
- Supported by funding from the National Institutes of Health, this research demonstrates the transformative impact of strategic investment in biomedical engineering on viral diagnostics.
- Looking ahead, further development and clinical testing of LUCAS aim to evaluate its performance in detecting viral pathogens across a wider range of bodily fluids and patient populations.
Read Full Article
11 Likes
For uninterrupted reading, download the app